{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T10:19:46Z","timestamp":1706005186413},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T00:00:00Z","timestamp":1253232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s12185-009-0423-1","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T02:15:36Z","timestamp":1253153736000},"page":"597-600","source":"Crossref","is-referenced-by-count":3,"title":["Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?"],"prefix":"10.1007","volume":"90","author":[{"given":"Saloni","family":"Tanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celalettin","family":"Ustun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,18]]},"reference":[{"key":"423_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","volume":"142","author":"K Sawada","year":"2008","unstructured":"Sawada K, Fujishimai N, Hirokawai M. Acquired pure red cell aplasia: updated review of treatment. Brit J Haem. 2008;142:505\u201314.","journal-title":"Brit J Haem"},{"key":"423_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1526-0968.1999.00135.x","volume":"3","author":"C Ust\u00fcn","year":"1999","unstructured":"Ust\u00fcn C, Celebi H, Arat M, Ozcan M, Dilek I, G\u00fcrman G, et al. Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case report. Ther Apher. 1999;3:275\u20137.","journal-title":"Ther Apher"},{"key":"423_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0925-5710(97)00061-3","volume":"66","author":"C Ust\u00fcn","year":"1997","unstructured":"Ust\u00fcn C, Karavelio\u011flu D, Ilhan O, Aydintug O, Beksac M. A case report of a patient who has pure red cell aplasia and rheumatoid arthritis. Int J Hematol. 1997;66:505\u201312.","journal-title":"Int J Hematol"},{"key":"423_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF01910315","volume":"71","author":"F Gilsanz","year":"1995","unstructured":"Gilsanz F, Garcia Vela J, Vargas JA, Iba\u00f1ez J, Ona F, Lopez J, et al. Acquired pure red cell aplasia: a study of six cases. Ann Hematol. 1995;71:181\u20133.","journal-title":"Ann Hematol"},{"key":"423_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2257.1989.tb00243.x","volume":"11","author":"A L\u00f3pez-Guillermo","year":"1989","unstructured":"L\u00f3pez-Guillermo A, Cervantes F, Sacanella E, Florensa L, Rozman C. Pure red cell aplasia associated with chronic myelomonocytic leukaemia. Clin Lab Haematol. 1989;11:410\u20131.","journal-title":"Clin Lab Haematol"},{"key":"423_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2257.1989.tb00176.x","volume":"11","author":"PH Bolton-Maggs","year":"1989","unstructured":"Bolton-Maggs PH, Galloway MJ, Rhodes EG. Pure red cell aplasia heralding chronic myelomonocytic leukaemia. Clin Lab Haematol. 1989;11:61\u20135.","journal-title":"Clin Lab Haematol"},{"key":"423_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/bmj.284.6309.85","volume":"284","author":"DA Francis","year":"1982","unstructured":"Francis DA. Pure red cell aplasia: association with systemic lupus erythematosus and primary autoimmune hypothyroidism. Br Med J. 1982;284:85.","journal-title":"Br Med J"},{"key":"423_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1080\/10428190127501","volume":"42","author":"AP Grigg","year":"2001","unstructured":"Grigg AP, O\u2019Flaherty E. Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia. Leuk Lymph. 2001;42:1339\u201342.","journal-title":"Leuk Lymph"},{"key":"423_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/BF02982116","volume":"75","author":"T Yamauchi","year":"2002","unstructured":"Yamauchi T, Shirasaki H, Kuwata A, Yamashita T, Imamura S, Tsutani H, et al. Pure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after Cyclosporin A therapy. Int J Hematol. 2002;75:514\u20138.","journal-title":"Int J Hematol"},{"key":"423_CR10","unstructured":"Orazi A, Bennet JM, Germin U, et al. Chronic myelomonocytic leukemia. In: Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. 4th ed. France: Lyon; 2008:76."},{"key":"423_CR11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/leu.2008.119","volume":"22","author":"A Orazi","year":"2008","unstructured":"Orazi A, Germing U. The myelodysplastic\/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia. 2008;22:1308\u201319.","journal-title":"Leukemia"},{"key":"423_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1365-2141.1987.tb06858.x","volume":"65","author":"JM Ribera","year":"1987","unstructured":"Ribera JM, Cervantes F, Rozman C. A multivariate analysis of prognostic factors in chronic myelomonocytic leukemia according to FAB criteria. Br J Haematol. 1987;65:307\u201311.","journal-title":"Br J Haematol"},{"key":"423_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/1097-0142(197909)44:3<927::AID-CNCR2820440321>3.0.CO;2-O","volume":"44","author":"DL Barnard","year":"1979","unstructured":"Barnard DL, Burns GF, Gordon J, Cawley JC, Barker CR, Hayhoe FG, et al. Chronic myelomonocytic leukemia with paraproteinemia but no plasmacytosis. A detailed cytological and immunological study. Cancer. 1979;44:927\u201336.","journal-title":"Cancer"},{"key":"423_CR14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V63.3.634.634","volume":"63","author":"P Solal-Celigny","year":"1984","unstructured":"Solal-Celigny P, Desaint B, Herrera A, Amar M, Vroclans M, Brousse N, et al. Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. Blood. 1984;63:634\u20138.","journal-title":"Blood"},{"key":"423_CR15","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079\u201388.","journal-title":"Blood"},{"key":"423_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1182\/blood.V99.3.840","volume":"99","author":"F Onida","year":"2002","unstructured":"Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 2002;99:840\u20139.","journal-title":"Blood"},{"key":"423_CR17","first-page":"52","volume":"6","author":"C Aul","year":"1992","unstructured":"Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia. 1992;6:52\u20139.","journal-title":"Leukemia"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0423-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0423-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T08:14:33Z","timestamp":1590135273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0423-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,18]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0423-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,18]]}}}